Gabacaine (Page 9 of 9)

Warnings

Keep out of reach of children.

For external use only.

Flammable. Keep away from fire or flame.

Ingredients

Isopropyl alcohol, water

Other information

  • Protect from freezing, avoid excessive heat

Gabacaine — carton

image description
(click image for full-size original)

GABACAINE gabapentin, lidocaine kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:59088-738
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:59088-738-00 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 BOTTLE 9
Part 2 1 POUCH 0.7 g
Part 1 of 2
GABAPENTIN gabapentin capsule
Product Information
Item Code (Source) NDC:50436-0384
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GABAPENTIN (GABAPENTIN) GABAPENTIN 300 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
TALC
GELATIN, UNSPECIFIED
TITANIUM DIOXIDE
FD&C RED NO. 40
D&C YELLOW NO. 10
SODIUM LAURYL SULFATE
Product Characteristics
Color yellow (opaque yellow colored cap and opaque yellow colored body) Score no score
Shape capsule Size 19mm
Flavor Imprint Code SG;180
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:50436-0384-9 9 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204989
Part 2 of 2
LIDOCAINE lidocaine patch
Product Information
Item Code (Source) NDC:59088-396
Route of Administration CUTANEOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LIDOCAINE (LIDOCAINE) LIDOCAINE 50 mg in 1 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:59088-396-84 0.7 g in 1 POUCH None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA200675
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204989 05/03/2019
Labeler — PureTek Corporation (785961046)
Establishment
Name Address ID/FEI Operations
Actavis Laboratories UT, Inc. 079589880 manufacture (59088-396)

Revised: 05/2019 PureTek Corporation

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.